Fizyhealth
FountainRx for cash-pay

FountainRx for cash-pay clinics: why the economics diverge

FountainRx is built around insured specialty workflows: out-of-pocket cost is determined after insurance review and prior authorization when applicable, per its public FAQ. Cash-pay clinics that quote patients on semaglutide and tirzepatide margin before the visit need pass-through per-vial 503A pricing before checkout — a different economics model than FountainRx referral coordination.

If you run a cash-pay or concierge clinic and wonder whether FountainRx fits your GLP-1, hormone, and peptide refill day, this page explains where the pricing paths diverge — and how Fizy Health makes margin visible up front.

Compare Fizy Health vs FountainRx

Proudly Partnered With

What does FountainRx mean for cash-pay economics?

For cash-pay clinics, margin is the spread between landed 503A cost and patient price — visible before you quote. FountainRx's public FAQ states prescription cost varies by insurance coverage and deductible status, with out-of-pocket communicated after prior authorization when required. That path optimizes insured specialty patients with payor coordination, financial assistance programs, and patient education — not a prescriber batch cart where every cash-pay line shows pass-through per-vial cost before payment. Cash-pay GLP-1, hormone, and peptide clinics running refill day at volume typically need the latter.

Who feels the economics

Cash-pay margin needs numbers before the consult — FountainRx delivers them after PA.

In a cash-pay clinic, pricing visibility flows through three roles. FountainRx's insured-centric model serves them differently than a pass-through clinic platform.

  • Owners

    Founders setting self-pay program prices.

    Owners pricing cash-pay GLP-1 programs need per-vial 503A cost before checkout. FountainRx determines patient out-of-pocket after insurance and prior auth — a fit for insured specialty lines, not for quoting self-pay margin at scale before every consult.

  • Operators

    Staff running refill day, not referral intake.

    Cash-pay ops teams batch dozens of patient lines in one session. FountainRx's one-patient referral model with coordinator follow-up does not replace a single validated cart and one payment for the whole refill list.

  • Prescribers

    Providers quoting at the visit.

    Prescribers quoting cash-pay patients during a visit need live landed cost on the screen. FountainRx's pricing path arrives after payor review — too late for visit-time margin conversations on self-pay compounded protocols.

Why FountainRx and cash-pay batch ordering are different jobs

FountainRx excels when prior auth, payor verification, and patient financial assistance determine whether a complex therapy ships. Its public materials describe coordinators submitting prior auth, working with insurers, and notifying patients about out-of-pocket cost once that process completes. Cash-pay clinics skip that payor layer — the clinic pays the compounder and marks up to the patient — so the critical number is pass-through 503A landed cost on each line before checkout.

A cash-pay clinic evaluating FountainRx for GLP-1 volume should ask whether referral coordination solves a problem you actually have. If your patients pay self-pay and your bottleneck is batch checkout, SIG validation, and margin clarity — not insurance PA — FountainRx is the wrong category. Compare your top five SKUs on landed cost before checkout instead of assuming any specialty pharmacy optimizes cash-pay refill day.

How pass-through pricing protects cash-pay margin

Fizy Health shows resolved 503A per-vial cost on every catalog and cart line before checkout, with a disclosed facilitation fee at payment. Owners set patient prices on the same number the clinic will pay; prescribers quote at the visit on live cost; operators batch the refill day in one cart with validation before payment so rejected orders do not erode margin after checkout.

Many cash-pay clinics keep FountainRx for the insured specialty patients who need it and run self-pay GLP-1, hormone, and peptide lines through Fizy Health. The workflows coexist because the economics do not.

Which model fits your cash-pay clinic?

FountainRx fits if

FountainRx

Specialty referral hub with prior auth and patient coordination.

  • Your cash-pay clinic still refers insured or complex chronic patients who need prior auth coordination — separate from self-pay batch ordering.
  • Patient refill portals and financial assistance for payor-covered therapies matter more than one cart for every cash-pay patient today.
  • Your workflow is one patient referral at a time with care coordinators managing paperwork and status updates.
Consider Fizy Health if

Fizy Health

One cart for every patient today. Every pharmacy. One checkout.

  • You set patient prices off landed cost and need per-vial 503A cost visible before checkout on cash-pay GLP-1, hormone, and peptide lines.
  • You want the facilitation fee disclosed at payment with no hidden per-vial markup layer.
  • You batch refills across multiple 503A partners and want one cart, one validation pass, one checkout.
If you choose Fizy Health

What a cash-pay clinic gets from pass-through pricing.

These outcomes protect cash-pay margin when pricing is visible and orders are validated before you pay.

See all features
Keep evaluating FountainRx

More answers in the FountainRx evaluation guide.

See the full FountainRx guide
FAQ

What cash-pay clinics ask about FountainRx.

  • Definition

    What is FountainRx for cash-pay clinics?

    FountainRx is primarily an insured specialty referral pharmacy with out-of-pocket determined after insurance review and prior auth. Cash-pay clinics batching self-pay GLP-1 refills need pass-through pricing before checkout — a different category Fizy Health serves.

  • Pricing

    Can cash-pay clinics see per-vial cost on FountainRx before ordering?

    FountainRx's public FAQ describes cost varying by insurance coverage with out-of-pocket communicated after prior auth when required — not pass-through per-vial 503A catalog pricing before a clinic checkout.

  • GLP-1

    Is FountainRx the right fit for a high-volume cash-pay GLP-1 clinic?

    If your bottleneck is insured prior auth for complex therapies, FountainRx may fit those referrals. If your bottleneck is batch cash-pay refill day with margin visible before the consult, compare pass-through landed cost on your top SKUs in Fizy Health instead.

  • Coexistence

    Can a cash-pay clinic use both FountainRx and Fizy Health?

    Yes. Many clinics refer insured specialty patients to FountainRx for prior auth coordination while running self-pay GLP-1, hormone, and peptide batch ordering through Fizy Health. The workflows are not integrated but solve different problems.

  • Fees

    What should cash-pay clinics ask FountainRx about cost?

    Ask whether referred therapies include cash-pay paths, how out-of-pocket is calculated without insurance, and turnaround on prior auth for any insured patients you still refer. For self-pay batch lines, ask Fizy Health for pass-through per-vial cost on your top SKUs before checkout.

  • Alternative

    How does Fizy Health change cash-pay economics?

    Fizy Health shows pass-through per-vial 503A cost before checkout with a disclosed facilitation fee, batches refill day in one validated cart, and catches rejections before payment — built for cash-pay margin visibility, not payor prior auth coordination.

Sources reviewed June 2026

  • FountainRx public website (fountainrx.com, referral process, FAQs), reviewed June 2026.
  • FountainRx September 2024 press release on accreditations and 50-state licensure.
  • Fizy Health platform capabilities reflect the live product.
Evaluate with real numbers

See cash-pay margin before you order.

Compare pass-through pricing on your semaglutide and tirzepatide SKUs, build one cart, and place your first test batch. Free to start.

Fizy Health vs FountainRxStart Ordering Free